Kolexia
Leroy Harmony
Oncologie hémato.
Hôpital Haut-lévêque
Pessac, France
40 Activités
43 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Inflammation Pyodermite Fasciite nécrosante Leucémie-lymphome lymphoblastique à précurseurs B et T Chromosome Philadelphie Infections bactériennes

Industries

Sobi
4 collaboration(s)
Dernière en 2023
A+A
2 collaboration(s)
Dernière en 2020
Novartis
2 collaboration(s)
Dernière en 2023
Janssen
2 collaboration(s)
Dernière en 2023

Dernières activités

Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy.
Cancer medicine   26 février 2024
Levofloxacin to Prevent Bacterial Infection in Patients with Acute Myeloid Leukemia Treated By Azacitidine and Venetoclax: A Study from the Dataml Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse.
British journal of haematology   07 mai 2022
Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study.
Leukemia & lymphoma   04 janvier 2022
Clonal haematopoiesis and cardiovascular diseases: A growing relationship.
Archives of cardiovascular diseases   10 mars 2021
La Minute Kanopée #3
Youtube @ Association des Internes en Hématologie AIH   28 décembre 2020
Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis.
Journal of hematology   01 octobre 2020
Real-World Outcomes of Patients with Refractory or Relapsed -ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study.
Cancers   24 juillet 2020
Outcome of Relapsed or Refractory -Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study.
Cancers   25 mars 2020
Pyoderma gangrenosum misdiagnosed as necrotising fasciitis or a real association between the two?
Journal of the European Academy of Dermatology and Venereology : JEADV   03 avril 2019